In this episode, Dr Roger Barker joins us to discuss our current understanding of Parkinson's disease.
The first half of the conversation focuses on the disease process. Is Parkinson's a single disease or a group of connected diseases? How might this difference affect our thinking surrounding Parkinson's?
The discussion then switches to the development of cell and gene therapies for Parkinson's. The unique challenges of a cell therapy for the brain, as well as the efficacy of a neurotrophic factor 'GDNF', are both discussed.
Dr Barker is the professor of clinical neuroscience at the University of Cambridge, and a consultant neurologist at Addenbrooke’s hospital in Cambridge. His lab at the John van Geest Centre for Brain Repair is focused on better understanding both Parkinson's and Huntington's disease, as well as on developing therapies to treat these diseases.
More information can be found at the lab's website: http://www.thebarkerwilliamsgraylab.co.uk/